Evidence map›Paper›PMID 32444905›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2021

Bacterial biofilms in infective endocarditis: an in vitro model to investigate emerging technologies of antimicrobial cardiovascular device coatings.

Alexander Lauten, Marc Martinović, Laura Kursawe, Judith Kikhney, Klaus Affeld, Ulrich Kertzscher, Volkmar Falk, Annette Moter

Open access · hybridAbstract read
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Fluoroquinolones and Biofilm: A Narrative Review.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  9. The emerging challenge ofClinical microbiology reviews · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Alexander Lauten *Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Standort Berlin, Berlin, Germany. Alexander.Lauten@charite.de.
Marc Martinović *Department of Cardiology, Charité, Universitaetsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany. Marc.Martinovic@charite.de.ORCID http://orcid.org/0000-0002-9102-7975
Laura KursaweBiofilmcenter, Department of Microbiology, Infectious Diseases and Immunology, Charité, Universitaetsmedizin Berlin, Berlin, Germany.
Judith KikhneyDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Standort Berlin, Berlin, Germany.
Klaus AffeldInstitute for Cardiovascular Computer-Assisted Medicine, Labor für Biofluidmechanik, Charité, Universitaetsmedizin Berlin, Berlin, Germany.
Ulrich KertzscherInstitute for Cardiovascular Computer-Assisted Medicine, Labor für Biofluidmechanik, Charité, Universitaetsmedizin Berlin, Berlin, Germany.
Volkmar FalkDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Standort Berlin, Berlin, Germany.
Annette MoterBiofilmcenter, Department of Microbiology, Infectious Diseases and Immunology, Charité, Universitaetsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEDeutsches Herzzentrum der Charité · DEFranklin University · USGerman Centre for Cardiovascular Research · DE

Funding

Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung. Otto-Hess-Promotionsstipendium
6 · The paper itself

Abstract

objectiveIn spite of the progress in antimicrobial and surgical therapy, infective endocarditis (IE) is still associated with a high morbidity and mortality. IE is characterized by bacterial biofilms of the endocardium, especially of the aortic and mitral valve leading to their destruction. About one quarter of patients with formal surgery indication cannot undergo surgery. This group of patients needs further options of therapy, but due to a lack of models for IE prospects of research are low. Therefore, the purpose of this project was to establish an in vitro model of infective endocarditis to allow growth of bacterial biofilms on porcine aortic valves, serving as baseline for further research. METHODS AND

resultsA pulsatile two-chamber circulation model was constructed that kept native porcine aortic valves under sterile, physiologic hemodynamic and temperature conditions. To create biofilms on porcine aortic valves the system was inoculated with Staphylococcus epidermidis PIA 8400. Aortic roots were incubated in the model for increasing periods of time (24 h and 40 h) and bacterial titration (1.5 × 10

conclusionThese results demonstrate the establishment of a novel in vitro model for bacterial biofilm growth on porcine aortic roots mimicking IE. The model will allow to identify predilection sites of valves for bacterial adhesion and biofilm growth and it may serve as baseline for further research on IE therapy and prevention, e.g. the development of antimicrobial transcatheter approaches to IE.

Indexed as

BiofilmsAnimalsAnti-Bacterial AgentsAortic ValveBacteriaCoated Materials, BiocompatibleDisease Models, AnimalEndocarditis, BacterialHumansIn Situ Hybridization, FluorescenceMitral ValveProsthesis-Related InfectionsSwineAnti-Bacterial AgentsCoated Materials, BiocompatibleBiofilmBioreactorFluorescence in situ hybridizationInfective endocarditisIn vitro modelStaphylococcus epidermidis

Identifiers

PMID32444905
PMCPMC7907033
OpenAlexW3026928709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.